What is Tectonic Therapeutics's non-cash lease expense?

Tectonic Therapeutics (TECX) reported non-cash lease expense of $496K in Q1 2026.

How has Tectonic Therapeutics's non-cash lease expense changed year-over-year?

Tectonic Therapeutics's non-cash lease expense decreased by 2.9% year-over-year, from $511K to $496K.

Non-cash portion of operating lease cost — the difference between straight-line lease expense and actual cash rent payments.

Ginkgo BioworksDNA

$7.11M-3.6%

Ethos Technologies, Inc. LIFE

$232K+7.4%

Operating income-$27.3M-49.2%

Net income-$25.2M-58.7%

EPS (diluted)-$1.34-44.1%

Cash & equivalents$236.9M-22.8%

Total debt$4.9M+86.1%

Total equity$230.4M-23.5%

Total assets$246.6M-21.7%

Operating cash flow-$18.4M-40.7%

CapEx$19.0K-29.6%

Free cash flow-$18.4M-40.6%

Market cap$585.51M+58.3%

Enterprise value$353.51M+438%

Return on equity-31.4%—

Debt / equity0×0.0×

Current ratio18.5×-4.4×

Reported directly by Tectonic Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.

The official record: Tectonic Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Tectonic Therapeutics's non-cash lease expense?: Tectonic Therapeutics (TECX) reported non-cash lease expense of $496K in Q1 2026.
How has Tectonic Therapeutics's non-cash lease expense changed year-over-year?: Tectonic Therapeutics's non-cash lease expense decreased by 2.9% year-over-year, from $511K to $496K.
What does non-cash lease expense mean?: Non-cash portion of operating lease cost — the difference between straight-line lease expense and actual cash rent payments.